Krytantek

DRUG2 trials

Sponsors

Allergan S.A. DE C.V.., Laboratorios Sophia S.A de C.V.

Conditions

Glaucoma Primary Open AnglePrimary Open-angle Glaucoma

Phase 3

PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)

TerminatedNCT03193333

Laboratorios Sophia S.A de C.V.Primary Open-angle Glaucoma

Start: 2017-11-06End: 2024-10-30Updated: 2025-03-06

Unknown Phase

Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

CompletedNCT01737853

Allergan S.A. DE C.V..Glaucoma Primary Open Angle

Start: 2011-02-28End: 2012-06-30Updated: 2012-11-30

Related Papers

Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.

2014-12-1914 citations